OptMyCare developed the first in market solution that identifies and stratifies all healthcare conditions identifying emerging risk and cost with high accuracy enabling risk bearing entities to prioritize workforce and decrease disease progression.  

Developed by a team of certified medical experts with firsthand experience in fields most-
impacted by high-cost claims, OptMyCare uses cloud-based, AI health technology designed to
harmonize workflow for examining, treating, and processing medical cases. Our dynamic risk
stratification system results in improved patient outcomes, which leads to reduced
hospitalizations and procedures.
We deliver prediction accuracies above 90% within a secure, cloud-based, and user-friendly
digital infrastructure which can be seamlessly integrated into your workflow and has been
validated across several million claims.
OptMyCare is the first and only Precision Analytics Platform that executes patient-level risk-
stratification across the fifty-five most common chronic diseases to help you prioritize: 

Who needs intervention to bend the cost curve.

Why certain high-risk patients need intervention based on different disease conditions.

How to intervene with protocols developed by clinicians with decades of practice.

When to intervene based on acuity at the patient level.

For more information, visit opt-mycare.com.

OptMyCare is a cloud-based descriptive & predictive analytics SaaS product with precision prescriptive solution at a member level for all risk bearing entities. OptMyCare developed the first in market solution that identifies and stratifies all healthcare conditions identifying emerging risk and cost with high accuracy enabling risk bearing entities to prioritize workforce and decrease disease progression.

• eCART is a research-based, AI-driven software as a medical device (SaMD) that utilizes a machine learning algorithm to continuously assess hospitalized patients’ risk of impending death or intensive care unit (ICU) transfer, assisting medical staff in swift and accurate recognition of patients requiring increased medical attention. eCART draws upon readily available patient data from the EHR, rapidly quantifies disease severity, and predicts likelihood of critical illness onset, hours before it happens.
• eCART received FDA 510(k) clearance in 2024, with clinical performance data of nearly two million hospitalizations from 21 hospitals, including an unprecedented level of real-world prospective data, to ensure consistent accuracy across geography, age, race, and top medical conditions (e.g. sepsis, COPD, heart failure). 
• Built upon more than a decade of ongoing scientific research, eCART was developed at UChicago Medicine by Dr. Dana Edelson, MD, MS and Dr. Matthew Churpek, MD, PhD and is well chronicled in published literature. The analytic and workflow have been in use in clinical practice since 2016.

At AgileMD, we are building the most advanced real-time predictive analytics and clinical pathways platform for hospitals.

To date, AgileMD tools have been used on more than 4 million patient encounters by more than 135,000 clinical users in over 250 hospitals, including some of the nation's leading academic medical centers. AgileMD's eCART clinical deterioration prediction software is FDA cleared and the first AI-powered early warning device for ward patients to go through the FDA process with real-world prospective data. 

AgileMD is backed by premier start-up partners MATTER, YCombinator, and Rock Health, and our cutting-edge analytics are built on more than decade of ongoing research at the University of Chicago. In 2021, AgileMD garnered nearly $3 million in combined federal research and development funding from the U.S. Department of Health and Human Services (HHS), including the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA).

Pre-Mapped Clinical AI Models

Predictive & Prescriptive Analytics Beyond Descriptive-Alone

Pre-Mapped Clinical AI Models

High Accuracy

Speed to Value

• Continuously monitors EHR data in real time
• Stratifies hospitalized patients by risk of impending all-cause clinical deterioration and sepsis
• Notifies inpatient providers when patient may need additional assessment and management
• Recommends clinical pathways with integrated order entry

• Authorized: FDA 510(k) cleared
• Tested: Derived and validated in nearly 3 million patient encounters across 28 hospitals
• Experienced: 8+ years in clinical use; 10+ years of published academic literature on value over other early warning scores
• Accurate: High sensitiviy and specificity, meaning fewer false alarms and more efficient focus on the highest risk patients
• Integrated: Embedded cross-team workflow ensures that risk scores are not ignored and action is taken
• Benchmarked: Robust reporting, benchmarking, and implementation support drive quality improvement